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The anticoagulation warfarin is a commonly prescribed medication that has a
narrow therapeutic index and displays high inter- and intrasubject variability in
response. In the community there is also widespread, often unreported, self-
medication with a range of herbal medicines. The opportunity for potentially life-
threatening interactions between herbal medications and warfarin is thus high.
1
Shengmai-yin is one such herbal medicine that is commonly used for coronary
heart disease, cardiogenic shock, and septic shock for promoting microcirculation
and decreasing blood viscosity as well for a wide range of the other indications.
2-4
However, relatively little is known about shengmai-yin drug interactions. This is
the first report of an adverse interaction between warfarin and a combination herbal
product, shengmai-yin, resulting in cerebral bleeding.
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A 71-year-old man was stable on warfarin (2.25 mg daily) therapy with an
international normalized ratio (INR) of 1.8-2.2 after a heart valve replacement
surgery. Recently, he consumed the liquid-like herbal product called shengmai-yin
(10 mL daily) against medical advice. Seven days after the daily consumption of
shengmai-yin, he was admitted to the intensive care unit because of consciousness
disturbance [Glasgow Coma Scale (GCS) score 7] with an INR of 5.08. Head com-
puted topography revealed intracerebral hematoma in the left temporoparietal
region. Both warfarin therapy and the herbal product were withdrawn. At the same
time, therapy with intravenous vitamin K1 40 mg was started. On the second day
of admission, craniectomy was performed to remove the intacerebral hematoma
under general anesthesia. He remained confused and restless for 2 days, but then
showed progressive recovery in the consciousness level as well as motor and
verbal functions. Shengmai-yin contains herbal ingredients that can interact with
warfarin. The Drug Interaction Probability Scale (DIPS) indicated that warfarin
and shengmai-yin were highly probable causes of intracerebral hematoma. Pati-
ents on warfarin therapy should be discouraged from taking herbal medicines,
especially preparations that are already known to have antiplatelet and antithrom-
botic effects.
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A 71-year-old man was admitted to the intensive care unit
following consciousness disturbance for 5 hours. His initial
Glasgow Coma Scale (GCS) score was 7. He had right
hemiplegia and active pupils, 3 mm on the two sides. Head
computed tomography (CT) on admission showed an
intracerebral hemotoma in the left temporoparietal region
causing marked midline shift to the right, and a tubular high-
density area in the left temporal lobe (Fig. 1). Laboratory
studies revealed prothrombin time (PT) was prolonged to 66
seconds with an international normalized ratio (INR) 5.08.
Renal and liver function tests were normal. Chest X-ray
revealed no abnormality.
The patient received aortic valve and mitral valve repla-
cement one year ago and his heart function restored to
New York Heart Association Class I. He was receiving
warfarin therapy after surgery. He was followed in the
medical clinic every 4 weeks. His INR was mostly in the
range of 1.8-2.2 (Fig. 2), except during the dose titration in
the first month of warfarin therapy. During the medical
clinical visit a half of year ago, the patient felt well and he
stated that he was taking all of the prescribed drugs follow-
ing medical advice. The INR value was 1.9 three month
ago and 2.0 one month ago. The patient’s blood pressure
has been well-controlled since he was diagnosed hyper-
tension.
When admitted to the intensive care unit (ICU), the
patient’s wife stated that he only took the prescribed
medications. There were no recent changes in the amount
of vegetable (vitamin K) intake. On further questioning,
however, the old lady said that the patient started to take a
kind of Chinese herb called shengmai-yin (Kanghua
pharma Inc., Jiaozuo, Henan, China), because he believed
that shengmai-yin was helpful for his heart disease. He
took it 10 mL daily beginning 7 days prior to admission.
On admission to the ICU, vitamin K1 40 mg was adminis-
tered first and the INR decreased to 1.67, PT to 19 seconds.
Craniectomy was performed to remove the intracerebral
hematoma under general anesthesia. He remained confused
and restless for 2 days, but then showed progressive reco-
very in a consciousness level as well as motor and verbal
functions. The patient was discharged on warfarin dose
2.25 mg daily; his INR was 2.0. Lotensin 5 mg daily con-
tinued. He was advised not to take shengmai-yin and other
herbal medicines because of the risk of loss of anticoagula-
tion control. After 6 months, he was able to walk by himself,
without any bleeding complications and alterations in INR
to a value > 3.0. 
During the first year of warfarin therapy, this patient never
had any bleeding complications and alterations in INR to a
value > 5.0 until he took the Chinese herb, shengmai-yin.
In the absence of other precipitating factors, the temporal
relationship between shengmai-yin consumption and the
onset of bleeding in the brain suggested that this herbal
product was responsible for the loss of anticoagulation
control. An objective causality assessment using the Drug
Interaction Probability Scale (DIPS)
5 revealed that the ob-
served reaction was highly probable to be related to con-
comitant use of warfarin and herbal product, shengmai-yin.
Shengmai-yin is a popular Chinese combination herbal
product, which was developed on the base of a thousand-
year-old traditional Chinese medicine prescription, sheng-
mai-san. Traditional Chinese theory believed that shengmai-
yin has the effect of supplementing Qi and nourishing Yin,
fu mai and improving peripheral circulation. Shengmai-san
is commonly used for its effect on oxidative damage in
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Fig. 1. Preoperative computed tomography scans showing left frontoparietal
hematoma with midline shift.
Fig. 2.The INR values of the patient 6 months before (values with minus on hori-
zontal ordinate), during, and 6 months after (values with plus on horizontal ordi-
nate) administration of shengmai-yin. The arrow indicates that time when the
patients began administration of shengmai-yin. INR, international normalized ratio.
DISCUSSIONheart, brain, and other tissues.
6-8 Although it has been appli-
ed for heart and blood diseases, routinely and prophylacti-
cally for thousands of years in China,
2-4 little available
clinical data showed that it could cause apparent bleeding.
It contains hongsheng (red ginseng), maidong (liriope),
and wuweizi (schisandra chinensis). There are many
different types of red ginseng, such as rhizoma ginseng
rhbra, radix ginseng rhbra (1 year), radix ginseng rhbra (2
year), North Korea radix ginseng rhbra, radix ginseng
rhbra (ordinary), and radix ginseng rhbra (xinkaihe). All
contains different amounts of ginsenoside Rg1, Re, and Rb1.
9
Case reports and healthy volunteer trials have had confli-
cting results, some reporting a potentiating
10-14 and others a
reductive influence.
15-19 Previous studies
10-13 have suggested
that red ginseng was associated with an altered INR
occurred in this patient. In 1998, Nakajima, et al.
12 demon-
strated that red ginseng was observed to increase the pro-
duction of Interleukin 1 beta, which is known to play im-
portant roles in the homeostatic activities of the human body
such as increasing the production of tissue plasminogen
activators, which suppress the formation of thrombin in the
blood coagulation and fibrinolysis mechanisms. In a later
study, Lü, et al.
14 confirmed these findings. Their study
revealed that Rg1 down regulates plasminogen inhibitor 1
(PAI-1), tissue factor pathway inhibitor, coagulation factor
XIII, A1, and, coagulation factor II (thrombin) receptor
(F2R). A recent study by Jin, et al.
10 suggested that Korean
red ginseng has a potent antithrombotic effect in vivo, which
may be due to antiplatelet rather that anticoagulation
activity. In contrast, Jiang et al.
15 showed that co-adminis-
tration of warfarin with ginseng did not affect the phar-
macokinetics or pharmacodynamics of either S-warfarin or
R-warfarin in healthy subjects in 2004. Recently, Lee, et
al.
16 also found that co-administration of panax ginseng and
warfarin in ischemic stroke patients does not influence the
pharmacologic action of warfarin. Later study by Jiang, et
al.
17 demonstrated that Asian ginseng could actually mo-
destly increase the clearance of warfarin and decrease its
effectiveness. In addition, Mu, et al.
20 found that the admini-
stration of wuweizi, another essential component of sheng-
mai-yin, can increase the metabolism and decrease the
levels of warfarin in animal models due to CYP2C9
induction. 
Drug interactions occur at varying rates in patients. The
causes for variability include Genetics, diseases, diet/nutri-
tion, environment, smoking, and alcohol use. The indivi-
dual Genetic traits underlying increased or decreased the
effect of drug co-administered other drugs are unknown.
The Genetic trait needs further investigation for this case.
Intracerebral bleeds due to trauma, rupture of an aneu-
rysm or arteriovenous malformation (AVM), and bleeding
within a tumor. A very small proportion is due to cerebral
venous sinus thrombosis. High blood pressure raises the
risk of spontaneous intracerebral hemorrhage by two to six
times.
21 The patient suffered from hypertention for many
years, but he took antihypertensive (agent) at a regular
base and blood pressure was well-controlled. He had no
trauma history and head CT showed no other abnormalities.
However, the effect of shengmai-yin on coagulation pro-
gress was controversial. In this patient, loss of anticoagula-
tion control was more likely after consumption of shengmai-
yin, possibly due to its potentiating effect on the normal
coagulation progress. Warfarin has a narrow therapeutic
index. Patients should be counseled to avoid herbal medica-
tion that can interact with warfarin. It is important to take a
detailed history regarding the use of all drugs and herbal
medicines, especially in patients with anticoagulant therapy. 
The work was performed in First Affiliated Hospital, School
of Medicine, Zhejiang University, Hangzhou, China.
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ment of Science and Technology, No2006C30014.
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